1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic landscape, clinical characteristics and outcomes of early onset (EO) compared with average onset (AO) colorectal cancer (CRC)
    Meeting Abstract

    Dos Santos Fernandes, G.; Chatila, W. K.; Yaeger, R.; Mendelsohn, R. B.; Stadler, Z. K.; Segal, N. H.; Varghese, A. M.; Lagunes, D. R.; Diaz, L. A.; Shia, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase II trial of sorafenib plus doxorubicin (SD) in patients (Pts) with advanced hepatocellular carcinoma (HCC) after progression of disease (PD) on sorafenib (S)
    Meeting Abstract

    El Dika, I. H.; Capanu, M.; Chou, J. F.; Harding, J. J.; Hrabovsky, A. D.; Do, R. K. G.; Shia, J.; Germino, J.; O'Reilly, E. M.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Causal modeling of CALGB 80405 (Alliance) to identify network drivers of metastatic colorectal cancer (CRC)
    Meeting Abstract

    Das, R. K.; Furchtgott, L.; Meyerhardt, J. A.; Nixon, A. B.; Innocenti, F.; Cunha, D.; Rich, K.; Lenz, H. J.; Niedzwiecki, D.; O'Reilly, E. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Emergency department (ED) presenting symptom clusters for chemotherapy patients
    Meeting Abstract

    Daly, R. M.; Nicholas, K.; Gorenshteyn, D.; Sokolowski, S.; Gazit, L.; Adams, L.; Matays, J.; Katzen, L. L.; Chiu, O. O.; Xiao, H.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A bi-institutional phase II study of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (Dex) combined with systemic gemcitabine and oxaliplatin (GemOx) for unresectable intrahepatic cholangiocarcinoma (ICC)
    Meeting Abstract

    Cercek, A.; Kemeny, N. E.; Boerner, T.; Tan, B. R.; Chou, J. F.; Gonen, M.; Boucher, T. M.; Hauser, H.; Do, R. K. G.; Lowery, M. A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prevalence of germline genetic alterations in colorectal cancer patients
    Meeting Abstract

    Cercek, A.; Kemel, Y.; Mandelker, D.; Stewart, C.; Arnold, A. G.; Sheehan, M.; Yaeger, R.; Segal, N. H.; Varghese, A. M.; Saltz, L. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • KEYNOTE-585: Phase 3 study of chemotherapy (chemo) + pembrolizumab (pembro) vs chemo + placebo as neoadjuvant/adjuvant treatment for patients (pts) with gastric or gastroesophageal junction (G/GEJ) cancer
    Meeting Abstract

    Bang, Y. J.; Van Cutsem, E.; Fuchs, C. S.; Ohtsu, A.; Tabernero, J.; Ilson, D. H.; Hyung, W. J.; Strong, V. E.; Goetze, T. O.; Yoshikawa, T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • High frequency mismatch repair (MMR) pathway mutations in adrenocortical carcinoma: Indication for routine MMR-deficiency (MMR-D) testing
    Meeting Abstract

    Akala, O. O.; Kelly, V.; Strong, V. E.; Gopalan, A.; Reidy, D. L.; Raj, N. P.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase 1/2 dose-escalation and expansion study of a conditionally active anti-AXL humanized monoclonal antibody (BA3011) in patients with advanced solid tumors
    Meeting Abstract

    Ahnert, J. R.; Taylor, M. H.; O'Reilly, E. M.; Zhang, J.; Doebele, R. C.; Ben, Y.; Sharp, L. L.; Boyle, W. J.; Chang, C.; Frey, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A randomized, multicenter phase 3 study of durvalumab (D) and tremelimumab (T) as first-line treatment in patients with unresectable hepatocellular carcinoma (HCC): HIMALAYA study
    Meeting Abstract

    Abou-Alfa, G. K.; Chan, S. L.; Furuse, J.; Galle, P. R.; Kelley, R. K.; Qin, S.; Armstrong, J.; Darilay, A.; Vlahovic, G.; Negro, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save